Get your appointment reminders by text!
Text HEARTPLACE to 622622
or scan the QR CODE with your smart phone.
Dr. Routh specializes in Interventional Cardiology and Cardiovascular Disease.
Fellow of the American College of Cardiology (FACC).
Chief Fellow, University of Rochester, 2012-2013.
Dr. Gautam Reddy is a graduate of the Gandhi Medical College in Hyderabad, India and completed Residency at the University of Connecticut.
Dr. Ferry specializes in Interventional Cardiology and Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
"Dr. HeartPlace would like to introduce our newest provider, Dr. M. Kevin Graves, M.D., F.A.C.C. practicing at the new HeartPlace Mesquite clinic. Dr. Graves joins HeartPlace with over 20 years of experience. His formal training was with LSU School of Medicine in New Orleans and served as Chief Resident in Internal Medicine at Charity Hospital New Orleans in 1992-93. After several years practicing as a hospitalist in Internal Medicine, he went back to fellowship training in Cardiology. He is board certified in Cardiovascular Diseases as well as Advanced Heart Failure and Transplant Cardiology. He also has a special interest in Cardioncology, treating and preventing cancer therapy complications. He is a Fellow of the American College of Cardiology, as well as a member of the Heart Failure Society of America, the International Society for Heart and Lung Transplant, and the International Cardioncology Society/North America You can visit Dr. Graves at our new HeartPlace Mesquite clinic located at 1675 Republic Parkway, Suite 100 in Mesquite, Texas. Call 972-620-9111 to make your appointment today! Read More
Critical conditions associated with the blockage of blood vessels are one of the primary health concerns worldwide. The main objective of emergency assistance in such conditions is to effectively implement thrombolysis, i.e. to quickly dissolve the clot. To this end, scientists from ITMO University in cooperation with Mariinsky Hospital in Saint Petersburg have developed a magnetically controlled drug that can be condensed on a blood clot by means of a magnetic field. The new drug is safe for intravenous injection and can dissolve clots up to 4000 times more efficiently than ordinary enzyme-based drugs. Read More
The formation of blood clots in the veins known as venous thromboembolism is the most common cause of preventable death in hospitals. A new study has now revealed that significant numbers of patients are not receiving recommended treatment to prevent these clots from forming - even after health care providers underwent educational programs. Source: Medical News Today Read More Read More
Chronic use of some drugs for heartburn and gastroesophageal reflux (GERD) speeds up the aging of blood vessels, according to a published paper in Circulation Research (early online), an American Heart Association journal. This accelerated aging in humans could lead to increased cardiovascular disease, vascular dementia and renal failure.
Higher leisure time physical activity is associated with a lower risk of developing heart failure, according to a study published online Sept. 2 in Circulation: Heart Failure. Kasper Andersen, M.D., Ph.D., from Uppsala University Hospital in Sweden, and colleagues evaluated responses to a questionnaire of lifestyle factors and medical history for 39,805 individuals without baseline heart failure in 1997. They assessed the total and direct effects of self-reported total and leisure-time physical activity on the risk of heart failure of any cause and heart failure of non-ischemic origin. Read More Read More